In partial fulfillment of the requirements for the Specialized Master of Science degree in the School of Biomedical Sciences, Matthew Levesque will present a seminar entitled, “Long Term Safety and Efficacy of Stereotactic Ablative Radiotherapy (SAbR) for Oligometastatic Renal Cell Carcinoma” on March 23, 2023, at 3:00 p.m., CST in EAD 719. The campus community is invited to attend. A private defense with the advisory committee will immediately follow the seminar.
Matthew Levesque is a candidate for Clinical Research Management, under the supervision of Umesh Sankpal, Ph.D., Professor.